ClariMed, Inc., the premier human-centered medical device development and regulatory services company, today announced the opening of its advanced ...

CEOs plan AI integration, but only 1.7% feel fully prepared. New research highlights what's getting in the way of progress – ...

Research shows that showing gamblers counter-advertising videos to expose industry tactics may help gamblers resist ...

The abstract, Phase 1 Dose-Escalation Study of Next-Generation Nectin-4 Targeting Antibody-Drug Conjugate CRB-701 (SYS6002) in US And UK Patients with Urothelial Cancer and other Solid Tumors ( Perez, ...

Study Group will be back with high-octane action on the second last week of its completion. Read to know where to watch it and what all to expect.

The generative AI market doubled in size in 2024 and is expected to reach or exceed $100 billion by 2028.In 2024, only 22% of ...

From antiaging treatments to lavish health-focused vacations, rich Gen Zers are spending on luxury brands and experiences ...

[KAMPALA] Poor regulation and lack of transparency in Africa’s fertility industry leave sperm donors and recipients ...

British youth were cut off from the benefits of youth mobility when the UK introduced its brexit rules in 2019. Many feel ...

Cambridge satchel on sale company logo The Cambridge Satchel Company EshopWedrop.ro on sale, London Fashion Week The ...

The Yorkshire & Humber Institute of Technology is inviting students from schools on the Yorkshire Coast to take part in its ...

Corbus Pharmaceuticals (CRBP) announced that data from its US and UK conducted first-in-human dose escalation clinical study of CRB-701 is ...